Consumer Attitudes & Behavior

In January, the U.S. FDA said a preliminary review showed no evidence of such a link, though the agency said it could not rule out that ‘a small risk may exist.’

A new article in the Journal of Pain looked at the results of 16 randomized, double-blind trials published on CBD and pain since 2019.

A 24-week randomized clinical trial compares low-dose oral minoxidil and topical minoxidil solution for male androgenetic alopecia.

Researchers from the University of Toronto say the annual number of opioid-related deaths doubled in Canada to 6,200 between 2019 and the end of 2021.

Drinks promoted as offering mental or physical benefits beyond hydration are growing in popularity.

A small study found that participants with serious mental illness significantly reduced their symptoms, lost weight and reversed metabolic syndrome.

These three major assumptions appear over and over in supplement marketing.

Clinicians can offer broad estimates of survival—in days to weeks, weeks to months, or months to years. But patients and care partners often want greater precision.